World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
61
Citations
11983
World Ranking
11461
National Ranking
786

Overview

Masatoshi Jinnin is affiliated with Wakayama Medical University in Japan. Their primary field of research is Medicine, with a significant focus on several subfields including Dermatology, Pathology and Forensic Medicine, Surgery, Oncology, and Genetics.

The research topics covered extensively in their work include:

  • Systemic Sclerosis and Related Diseases
  • Vascular Malformations and Hemangiomas
  • Dermatologic Treatments and Research
  • Vascular Tumors and Angiosarcomas
  • Vascular Malformations Diagnosis and Treatment
  • Tumors and Oncological Cases
  • Dermatology and Skin Diseases

Masatoshi Jinnin has published numerous papers, with some of the recent works including:

  • ISSVA Classification of Vascular Anomalies and Molecular Biology, 2022, International Journal of Molecular Sciences
  • Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune-checkpoint inhibitors, 2020, Cancer Science
  • Japanese clinical practice guidelines for vascular anomalies 2017, 2020, Japanese Journal of Radiology
  • Human Leukocyte Antigens and Biomarkers in Type 1 Diabetes Mellitus Induced by Immune-Checkpoint Inhibitors, 2022, Endocrinology and Metabolism
  • Japanese clinical practice guidelines for vascular anomalies 2017, 2020, Pediatrics International

Frequent co-authors who have collaborated with Masatoshi Jinnin include:

  • Yuki Yamamoto
  • Yutaka Inaba
  • Kayo Kunimoto
  • Chikako Kaminaka
  • Shin-ichi Murata

The scientist's publications commonly appear in the following journals:

  • The Journal of Dermatology
  • Drug Discoveries & Therapeutics
  • Skin Cancer
  • Trends in Immunotherapy
  • Modern Rheumatology Case Reports

Best Publications

  • Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-β1-induced extracellular matrix expression

    Masatoshi Jinnin;Hironobu Ihn;Kunihiko Tamaki

  • Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma.

    Masatoshi Jinnin;Damian Medici;Lucy Park;Nisha Limaye

  • Increased Expression of Integrin αvβ3 Contributes to the Establishment of Autocrine TGF-β Signaling in Scleroderma Fibroblasts

    Yoshihide Asano;Hironobu Ihn;Kenichi Yamane;Masatoshi Jinnin

  • Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis

    Nobuyo Higashi-Kuwata;Masatoshi Jinnin;Takamitsu Makino;Satoshi Fukushima

  • Impaired IL-17 signaling pathway contributes to the increased collagen expression in scleroderma fibroblasts

    Taiji Nakashima;Masatoshi Jinnin;Keitaro Yamane;Noritoshi Honda

  • The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker

    Hisashi Kanemaru;Satoshi Fukushima;Junji Yamashita;Noritoshi Honda

  • Myasthenic crisis and polymyositis induced by one dose of nivolumab

    Toshihiro Kimura;Satoshi Fukushima;Azusa Miyashita;Jun Aoi

  • Increased Expression of Integrin αvβ5 Induces the Myofibroblastic Differentiation of Dermal Fibroblasts

    Yoshihide Asano;Hironobu Ihn;Kenichi Yamane;Masatoshi Jinnin

  • The Downregulation of microRNA let-7a Contributes to the Excessive Expression of Type I Collagen in Systemic and Localized Scleroderma

    Katsunari Makino;Masatoshi Jinnin;Ayaka Hirano;Keitaro Yamane

  • Mechanisms of skin fibrosis in systemic sclerosis

    Masatoshi Jinnin

  • TGF-β–Mediated Downregulation of MicroRNA-196a Contributes to the Constitutive Upregulated Type I Collagen Expression in Scleroderma Dermal Fibroblasts

    Noritoshi Honda;Masatoshi Jinnin;Ikko Kajihara;Takamitsu Makino

  • Involvement of αvβ5 integrin–mediated activation of latent transforming growth factor β1 in autocrine transforming growth factor β signaling in systemic sclerosis fibroblasts

    Yoshihde Asano;Hironobu Ihn;Hironobu Ihn;Kenichi Yamane;Masatoshi Jinnin

  • miR-150 down-regulation contributes to the constitutive type I collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin β3.

    Noritoshi Honda;Masatoshi Jinnin;Tomomi Kira-Etoh;Katsunari Makino

  • Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.

    Masatoshi Jinnin;Hironobu Ihn;Yoshihide Asano;Kenichi Yamane

  • Antagonistic Effects of TNF-α on TGF-β Signaling Through Down-Regulation of TGF-β Receptor Type II in Human Dermal Fibroblasts

    Kenichi Yamane;Hironobu Ihn;Yoshihide Asano;Masatoshi Jinnin

  • Angiopoietin-like Protein 2 is an Important Facilitator of Inflammatory Carcinogenesis and Metastasis

    Jun Aoi;Motoyoshi Endo;Tsuyoshi Kadomatsu;Keishi Miyata

  • Down-Regulation of mir-424 Contributes to the Abnormal Angiogenesis via MEK1 and Cyclin E1 in Senile Hemangioma: Its Implications to Therapy

    Taiji Nakashima;Masatoshi Jinnin;Tomomi Etoh;Satoshi Fukushima

  • microRNA-mediated keratinocyte hyperproliferation in psoriasis vulgaris

    A. Ichihara;M. Jinnin;K. Yamane;A. Fujisawa

  • Intratumoral expression levels of PD-L1, GZMA, and HLA-A along with oligoclonal T cell expansion associate with response to nivolumab in metastatic melanoma.

    Hiroyuki Inoue;Jae Hyun Park;Kazuma Kiyotani;Makda Zewde

  • Basic fibroblast growth factor stimulates the proliferation of human dermal fibroblasts via the ERK1/2 and JNK pathways

    T. Makino;M. Jinnin;F.C. Muchemwa;S. Fukushima

Frequent Co-Authors

Hironobu Ihn
Hironobu Ihn Kumamoto University
Yoshihide Asano
Yoshihide Asano University of Tokyo
Kunihiko Tamaki
Kunihiko Tamaki University of Tokyo
Manabu Fujimoto
Manabu Fujimoto Osaka University
Minoru Hasegawa
Minoru Hasegawa University of Fukui
Shinichi Sato
Shinichi Sato University of Tokyo
Kazuhiko Takehara
Kazuhiko Takehara Kanazawa University
Osamu Ishikawa
Osamu Ishikawa Gunma University
Tsuneyo Mimori
Tsuneyo Mimori Kyoto University
Yuichi Oike
Yuichi Oike Kumamoto University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

A background in Biology or Biochemistry opens doors beyond laboratory research. Many graduates explore career paths in healthcare data and management, which are rapidly growing fields. For instance, becoming a certified professional coder can be an excellent pathway, blending science knowledge with healthcare administration.

If you’re considering this route, you might wonder how long does it take to become a medical coder. Training programs and certifications can take several months to a year, depending on the route you choose. The field offers job stability and diverse settings, from hospitals to insurance companies.

The medical coding job outlook is strong, with demand expected to grow as the healthcare industry expands. Remote and hybrid work opportunities are also increasing.

Interested in a management role? Consider one of the most affordable online health information management degree programs. These programs offer flexible study options and can significantly broaden your career choices in health data management and administration.

Best Scientists Citing Masatoshi Jinnin

Trending Scientists

Recently Published Articles